TY - JOUR
T1 - Ablation of Inappropriate Sinus Tachycardia
T2 - A Systematic Review of the Literature
AU - Rodríguez-Mañero, Moisés
AU - Kreidieh, Bahij
AU - Al Rifai, Mahmoud
AU - Ibarra-Cortez, Sergio
AU - Schurmann, Paul
AU - Álvarez, Paulino A.
AU - Fernández-López, Xesús Alberte
AU - García-Seara, Javier
AU - Martínez-Sande, Luis
AU - González-Juanatey, José Ramón
AU - Valderrábano, Miguel
N1 - Publisher Copyright:
© 2017 American College of Cardiology Foundation
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Objectives The goal of this study was to describe short- and long-term outcomes in all patients referred for inappropriate sinus tachycardia ablation, along with the potential complications of the intervention. Background Sinus node (SN) ablation/modification has been proposed for patients refractory to pharmacological therapy. However, available data derive from limited series. Methods The electronic databases MEDLINE, Embase, CINAHL, Cochrane, and Scopus were systematically searched (January 1, 1995–December 31, 2015). Studies were screened according to predefined inclusion and exclusion criteria. Results A total of 153 patients were included. Their mean age was 35.18 ± 10.02 years, and 139 (90.8%) were female. All patients had failed to respond to maximum tolerated doses of pharmacological therapy (3.5 ± 2.4 drugs). Mean baseline heart rates averaged 101.3 ± 16.4 beats/min according to electrocardiography and 104.5 ± 13.5 beats/min according to 24-h Holter monitoring. Two electrophysiological strategies were used, SN ablation and SN modification, with the latter being used more. Procedural acute success (using variably defined pre-determined endpoints) was 88.9%. Consistently, all groups reported high-output pacing from the ablation catheter to confirm absence of phrenic nerve stimulation before radiofrequency delivery. Need of pericardial access varied between 0% and 76.9%. Thirteen patients (8.5%) experienced severe procedural complications, and 15 patients (9.8%) required implantation of a pacemaker. At a mean follow-up interval of 28.1 ± 12.6 months, 86.4% of patients demonstrated successful outcomes. The symptomatic recurrence rate was 19.6%, and 29.8% of patients continued to receive antiarrhythmic drug therapy after procedural intervention. Conclusions Inappropriate sinus tachycardia ablation/modification achieves acute success in the vast majority of patients. Complications are fairly common and diverse. However, symptomatic relief decreases substantially over longer follow-up periods, with a corresponding high recurrence rate.
AB - Objectives The goal of this study was to describe short- and long-term outcomes in all patients referred for inappropriate sinus tachycardia ablation, along with the potential complications of the intervention. Background Sinus node (SN) ablation/modification has been proposed for patients refractory to pharmacological therapy. However, available data derive from limited series. Methods The electronic databases MEDLINE, Embase, CINAHL, Cochrane, and Scopus were systematically searched (January 1, 1995–December 31, 2015). Studies were screened according to predefined inclusion and exclusion criteria. Results A total of 153 patients were included. Their mean age was 35.18 ± 10.02 years, and 139 (90.8%) were female. All patients had failed to respond to maximum tolerated doses of pharmacological therapy (3.5 ± 2.4 drugs). Mean baseline heart rates averaged 101.3 ± 16.4 beats/min according to electrocardiography and 104.5 ± 13.5 beats/min according to 24-h Holter monitoring. Two electrophysiological strategies were used, SN ablation and SN modification, with the latter being used more. Procedural acute success (using variably defined pre-determined endpoints) was 88.9%. Consistently, all groups reported high-output pacing from the ablation catheter to confirm absence of phrenic nerve stimulation before radiofrequency delivery. Need of pericardial access varied between 0% and 76.9%. Thirteen patients (8.5%) experienced severe procedural complications, and 15 patients (9.8%) required implantation of a pacemaker. At a mean follow-up interval of 28.1 ± 12.6 months, 86.4% of patients demonstrated successful outcomes. The symptomatic recurrence rate was 19.6%, and 29.8% of patients continued to receive antiarrhythmic drug therapy after procedural intervention. Conclusions Inappropriate sinus tachycardia ablation/modification achieves acute success in the vast majority of patients. Complications are fairly common and diverse. However, symptomatic relief decreases substantially over longer follow-up periods, with a corresponding high recurrence rate.
KW - inappropriate sinus tachycardia
KW - sinus node ablation
KW - sinus node modification
UR - http://www.scopus.com/inward/record.url?scp=85010651117&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010651117&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2016.09.014
DO - 10.1016/j.jacep.2016.09.014
M3 - Article
C2 - 29759520
AN - SCOPUS:85010651117
SN - 2405-500X
VL - 3
SP - 253
EP - 265
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 3
ER -